Canakinumab allows discontinuation of corticosteroids in patients with SJIA – EurekAlert (press release)
Canakinumab allows discontinuation of corticosteroids in patients with SJIAEurekAlert (press release)Madrid, Spain, 13 June 2013: Study findings first presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonst…